Placental Methylglyoxal in Preeclampsia: Vascular and Biomarker Implications
Open Access
- 1 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (7) , 1537-1549
Abstract
BACKGROUND: Preeclampsia is a multifaceted syndrome that includes maternal vascular dysfunction. We hypothesize that increased placental glycolysis and hypoxia in preeclampsia lead to increased levels of methylglyoxal (MGO), consequently causing vascular dysfunction. METHODS: Plasma samples and placentas were collected from uncomplicated and preeclampsia pregnancies. Uncomplicated placentas and trophoblast cells (BeWo) were exposed to hypoxia. The reactive dicarbonyl MGO and advanced glycation end products (N ε -(carboxymethyl)lysine [CML], N ε -(carboxyethyl)lysine [CEL], and MGO-derived hydroimidazolone [MG-H]) were quantified using liquid chromatography-tandem mass spectrometry. The activity of GLO1 (glyoxalase-1), that is, the enzyme detoxifying MGO, was measured. The impact of MGO on vascular function was evaluated using wire/pressure myography. The therapeutic potential of the MGO-quencher quercetin and mitochondrial-specific antioxidant mitoquinone mesylate (MitoQ) was explored. RESULTS: MGO, CML, CEL, and MG-H2 levels were elevated in preeclampsia-placentas (+36%, +36%, +25%, and +22%, respectively). Reduced GLO1 activity was observed in preeclampsia-placentas (−12%) and hypoxia-exposed placentas (−16%). Hypoxia-induced MGO accumulation in placentas was mitigated by the MGO-quencher quercetin. Trophoblast cells were identified as the primary source of MGO. Reduced GLO1 activity was also observed in hypoxia-exposed BeWo cells (−26%). Maternal plasma concentrations of CML and the MGO-derived MG-H1 increased as early as 12 weeks of gestation (+16% and +17%, respectively). MGO impaired endothelial barrier function, an effect mitigated by MitoQ, and heightened vascular responsiveness to thromboxane A2. CONCLUSIONS: This study reveals the accumulation of placental MGO in preeclampsia and upon exposure to hypoxia, demonstrates how MGO can contribute to vascular impairment, and highlights plasma CML and MG-H1 levels as promising early biomarkers for preeclampsia.Keywords
This publication has 52 references indexed in Scilit:
- Methylglyoxal, oxidative stress, and hypertensionCanadian Journal of Physiology and Pharmacology, 2006
- A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF‐1αFEBS Letters, 2005
- Inhibitory Effect of Naturally Occurring Flavonoids on the Formation of Advanced Glycation EndproductsJournal of Agricultural and Food Chemistry, 2005
- Placental Trophoblast-Derived Factors Diminish Endothelial Barrier FunctionThe Journal of Clinical Endocrinology & Metabolism, 2004
- Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxalAmerican Journal of Physiology-Renal Physiology, 2002
- Recent Insights into the Pathogenesis of Pre-eclampsiaPlacenta, 2002
- Endothelial junctional protein redistribution and increased monolayer permeability in human umbilical vein endothelial cells isolated during preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- The Assay of S-D-Lactoylglutathione in Biological SystemsAnalytical Biochemistry, 1993
- Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-LinkingScience, 1986